Terms: = Lymphoma AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809
1049 results:
1. Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review).
Zhang Y; Chu J; Hou Q; Qian S; Wang Z; Yang Q; Song W; Dong L; Shi Z; Gao Y; Meng M; Zhang M; Zhang X; Chen Q
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757347
[TBL] [Abstract] [Full Text] [Related]
2. Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.
Dobaño-López C; Valero JG; Araujo-Ayala F; Nadeu F; Gava F; Faria C; Norlund M; Morin R; Bernes-Lasserre P; Arenas F; Grau M; López C; López-Oreja I; Serrat N; Martínez-Farran A; Hernández L; Playa-Albinyana H; Giménez R; Beà S; Campo E; Lagarde JM; López-Guillermo A; Magnano L; Colomer D; Bezombes C; Pérez-Galán P
Blood Cancer J; 2024 May; 14(1):75. PubMed ID: 38697976
[TBL] [Abstract] [Full Text] [Related]
3. TYM-3-98, a novel selective inhibitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B-cell lymphomas.
Lou SY; Zheng FL; Tang YM; Zheng YN; Lu J; An H; Zhang EJ; Cui SL; Zhao HJ
Life Sci; 2024 Jun; 347():122662. PubMed ID: 38670450
[TBL] [Abstract] [Full Text] [Related]
4. [Reversal Effect of NVP-BEZ235 on Doxorubicin-Resistance in Burkitt lymphoma RAJI Cell Line].
Li CT; Zhu XP; Wang SX; Peng QY; Zheng Y; Liu SQ; Lu XD; Wang YS; Weng D; Wang D
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):476-482. PubMed ID: 38660855
[TBL] [Abstract] [Full Text] [Related]
5. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mtor and HIF-1α.
Incrocci R; Monroy Del Toro R; Devitt G; Salimian M; Braich K; Swanson-Mungerson M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612754
[TBL] [Abstract] [Full Text] [Related]
6. Concurrent inhibition of ALK and SRC kinases disrupts the ALK lung tumor cell proteome.
Diaz-Jimenez A; Ramos M; Helm B; Chocarro S; Frey DL; Agrawal S; Somogyi K; Klingmüller U; Lu J; Sotillo R
Drug Resist Updat; 2024 May; 74():101081. PubMed ID: 38521003
[TBL] [Abstract] [Full Text] [Related]
7. [leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) inhibits proliferation and promotes apoptosis of human HEL cells with JAK2 V617F mutation by blocking the JAK/STAT and PI3K/AKT signaling pathways].
Fan C; Zhang Y; Yang R; Wu X; Zhou J; Xue J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):207-214. PubMed ID: 38512030
[TBL] [Abstract] [Full Text] [Related]
8. Renin-Angiotensin System Inhibitors Suppress the Growth of Leukemia Cells.
Itoh M; Sasaki S; Tohda S
Anticancer Res; 2024 Mar; 44(3):1183-1192. PubMed ID: 38423665
[TBL] [Abstract] [Full Text] [Related]
9. Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Judd S; Revon-Riviere G; Grover SA; Deyell RJ; Vanan MI; Lewis VA; Pecheux L; Zorzi AP; Goudie C; Santiago R; Tran TH; Abbott LS; Brossard J; Moorehead P; Alvi S; Portwine C; Denburg A; Whitlock JA; Cohen-Gogo S; Morgenstern DA
Cancer Med; 2024 Feb; 13(3):e7033. PubMed ID: 38400668
[TBL] [Abstract] [Full Text] [Related]
10. Modulation of Apoptotic and Akt/PI3K/mtor pathways to target Glioblastoma Cells using synthetic compound PGEA-AN.
Saad S; Hanif F; Simjee SU; Faizi S; Khan L; Ashfaque A
J Pak Med Assoc; 2024 Feb; 74(1 (Supple-2)):S39-S46. PubMed ID: 38385470
[TBL] [Abstract] [Full Text] [Related]
11. Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by regulating the PI3K/AKT/mtor pathway.
Wu C; Chen S; Wu Z; Xue J; Zhang W; Wang S; Xindong Zhao ; Wu S
J Cancer Res Clin Oncol; 2024 Feb; 150(2):98. PubMed ID: 38381215
[TBL] [Abstract] [Full Text] [Related]
12. Sestrin 2 protects human lens epithelial cells from oxidative stress and apoptosis induced by hydrogen peroxide by regulating the mtor/Nrf2 pathway.
Tian X; Wei J
Int J Immunopathol Pharmacol; 2024; 38():3946320241234741. PubMed ID: 38379215
[TBL] [Abstract] [Full Text] [Related]
13. Development of Potent MALT1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-
Liang X; Yu H; Liang R; Feng Z; Saidahmatov A; Sun C; Ren H; Wei X; Zhao J; Yang C; Liu H
J Med Chem; 2024 Feb; 67(4):2884-2906. PubMed ID: 38349664
[TBL] [Abstract] [Full Text] [Related]
14. In vitro and in vivo anti-colorectal cancer effect of the newly synthesized sericin/propolis/fluorouracil nanoplatform through modulation of PI3K/AKT/mtor pathway.
Diab SE; Tayea NA; Elwakil BH; Elshewemi SS; Gad AAEM; Abdulmalek SA; Ghareeb DA; Olama ZA
Sci Rep; 2024 Jan; 14(1):2433. PubMed ID: 38286826
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides.
Bordeaux ZA; Reddy SV; Choi J; Braun G; McKeel J; Lu W; Yossef SM; Ma EZ; West CE; Kwatra SG; Kwatra MM
Sci Rep; 2024 Jan; 14(1):1955. PubMed ID: 38263212
[TBL] [Abstract] [Full Text] [Related]
16. Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage lymphoma axis-mediated activation of the phosphoinositide 3-kinase/Akt pathway.
Feng X; Yang L; Liu X; Liu M; Liu L; Liu J; Luo J
Med Oncol; 2024 Jan; 41(2):60. PubMed ID: 38252204
[TBL] [Abstract] [Full Text] [Related]
17. ATF5 promotes malignant T cell survival through the PI3K/AKT/mtor pathway in cutaneous T cell lymphoma.
Cao M; Lai P; Liu X; Liu F; Qin Y; Tu P; Wang Y
Front Immunol; 2023; 14():1282996. PubMed ID: 38223508
[TBL] [Abstract] [Full Text] [Related]
18. Targeting HDACs for diffuse large B-cell lymphoma therapy.
Wu C; Song Q; Gao S; Wu S
Sci Rep; 2024 Jan; 14(1):289. PubMed ID: 38168914
[TBL] [Abstract] [Full Text] [Related]
19. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
[TBL] [Abstract] [Full Text] [Related]
20. The role of α7-nAChR-mediated PI3K/AKT pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
[Next]
